Search

Your search keyword '"Castro Senosiain B"' showing total 27 results
Start Over Author "Castro Senosiain B"
27 results on '"Castro Senosiain B"'

2. P211 Impact of celiac disease on the outcome of Inflammatory Bowel Disease

Author

Alonso, I, primary, Ramos, L, additional, Hernández-Camba, A, additional, Yagüe-Caballero, C, additional, Vicente Lidón, R, additional, Taxonera, C, additional, García-Brenes, M A, additional, Gisbert, J P, additional, Chaparro, M, additional, Madero Velázquez, L, additional, Carrillo-Palau, M, additional, Arranz Hernández, L, additional, Castro Senosiain, B, additional, García de la Filia Molina, I, additional, Rojas-Feria, M, additional, López Romero-Salazar, F, additional, Bastón-Rey, I, additional, Sánchez-Azofra, M, additional, Riestra, S, additional, Pérez-Galindo, P, additional, Ortega Moya, S P, additional, Brunet-Mas, E, additional, Sanz Segura, P, additional, Caballero-Mateos, A M, additional, Calafat, M, additional, Botella Mateu, B, additional, Manceñido Marcos, N, additional, Rodríguez-Lago, I, additional, Suárez-Ferrer, C, additional, and Gutiérrez Casbas, A, additional

Published
2024
Full Text
View/download PDF

3. P118 Inflammatory Bowel Disease Unclassified and Ulcerative Colitis: different outcomes? Multicenter case-control study (Spanish ENEIDA registry)

Author

Gonzalez Vivo, M, primary, Urpí Ferreruela, M, additional, Castro Senosiain, B, additional, Pérez-Martínez, I, additional, Barrio, J, additional, Codesido Prado, L, additional, Caballol Oliva, B, additional, Pedrera Roman, V, additional, Piqueras Cano, M, additional, Rodríguez Moranta, F, additional, Casanova González, M J, additional, Ramos, L, additional, Iborra, M, additional, Tardillo Marin, C, additional, Barreiro-de Acosta, M, additional, Lorente Poyatos, R H, additional, Orts Jorquera, B, additional, Bujanda Fernández, L, additional, Zabana, Y, additional, López-García, A, additional, Riestra, S, additional, Vega-Villaamil, P, additional, Montoro, M, additional, Gisbert, J P, additional, Nos, P, additional, Rodriguez Gonzalez, G E, additional, Porto Silva, M, additional, Gutiérrez-Casbas, A, additional, Domenech, E, additional, and Márquez, L, additional

Published
2022
Full Text
View/download PDF

4. P410 Safety of biological drugs for inflammatory bowel disease in elderly patients

Author

Suarez Ferrer, C J, primary, Mesonero, F, additional, Caballol, B, additional, Ballester, M P, additional, Baston Rey, I, additional, Castaño Garcia, A, additional, Miranda Bautista, J, additional, Saiz Chumillas, R, additional, Benitez, J M, additional, Sanchez Delgado, L, additional, Lopez-Garcia, A, additional, Rubin de Celix, C, additional, Lopez Sanroma, A, additional, Martin-Arranz, M D, additional, Fernández-Clotet, A, additional, Merino Murgui, V, additional, Calviño Suárez, C, additional, Florez, P, additional, Lobato matilla, M E, additional, Sicilia, B, additional, Soto Escribano, P, additional, Maroto Martin, C, additional, Alonso Abreu, I, additional, Melcarne, L, additional, Plaza Santos, R, additional, Marques Cami, M, additional, Caballero Mateos, A, additional, Gómez Díez, C, additional, Calafat, M, additional, Alonso Galan, H, additional, Vega Villaamil, P, additional, Castro Senosiain, B, additional, Guerro Moya, A, additional, Rodriguez Diaz, C Y, additional, Spicakova, K, additional, Manceñido Marcos, N, additional, Molina, G, additional, De Castro, L, additional, Mañosa Ciria, M, additional, and Barreiro-De Acosta, M, additional

Published
2022
Full Text
View/download PDF

5. Characteristics and Treatment of Pyoderma Gangrenosum in Inflammatory Bowel Disease

Author

Argüelles-Arias, F., Castro-Laria, L., Lobatón, T., Aguas-Peris, M., Rojas-Feria, M., Barreiro-de Acosta, M., Soto-Escribano, P., Calvo-Moya, M., Ginard-Vicens, D., Chaparro-Sánchez, M., Hernández-Durán, M., Castro-Senosiain, B., Fernández-Villaverde, A., García-Sánchez, V., Domínguez-Muñoz, E., Caunedo-Álvarez, A., and Herrerías-Gutiérrez, J. M.

Published
2013
Full Text
View/download PDF

6. P338 effectiveness and safety of biological therapies in elderly inflammatory bowel diseases patients results from a multi center study of Geteccu

Author

Suarez Ferrer, C J, primary, Mesonero, F, additional, Caballol, B, additional, Saiz Chumillas, R, additional, Bastón-Rey, I, additional, Rubin de Celix, C, additional, Melcarne, L, additional, Caballero Mateos, A, additional, Calafat, M, additional, Alonso Galan, H, additional, Vega Villaamil, P, additional, Castro Senosiain, B, additional, Rodriguez Diaz, C Y, additional, Plaza Santos, R, additional, Marques Cami, M, additional, Rodriguez Grau, M C, additional, Ramirez, F, additional, Lopez-García, A, additional, Gomez Pastrana, B, additional, Gonzalez Partida, I, additional, Botella Mateu, B, additional, Cuevas del Campo, L, additional, Gonzalez Peña, E, additional, Iyo, E, additional, Elosua Gonzalez, A, additional, Sainz, E, additional, Hernandez, L, additional, Perez Galindo, P, additional, Rueda Garcia, J L, additional, Martin-Arranz, M D, additional, Lopez Sanroman, A, additional, Fernandez-Clotet, A, additional, Sicilia, B, additional, Calviño Suárez, C, additional, Mañosa Ciria, M, additional, and Barreiro-De Acosta, M, additional

Published
2021
Full Text
View/download PDF

8. P152 Should professionals provide their patients with digital health training resources?

Author

Echarri Piudo, A, primary, Molina Arriero, G, additional, Sierra Ausin, M, additional, Calvo Moya, M, additional, Pérez Calle, J L, additional, Fraga Iriso, R, additional, Morete Pérez, M C, additional, Botella Mateu, B, additional, Ollero Pena, V, additional, Enriquez Rodriguez, M, additional, Nos Mateu, P, additional, Castro Senosiain, B, additional, Martín Rodriguez, D, additional, and Mancenido Marcos, N, additional

Published
2020
Full Text
View/download PDF

11. Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

Author

Chaparro, María, primary, Donday, María G., additional, Barreiro-de Acosta, Manuel, additional, Domènech, Eugeni, additional, Esteve, María, additional, García-Sánchez, Valle, additional, Nos, Pilar, additional, Panés, Julián, additional, Martínez, Concepción, additional, Gisbert, Javier P., additional, Abad, F., additional, Aguas Peris, M., additional, Agüero Tejado, E., additional, Alba, C., additional, Albert, M., additional, Alemán, H., additional, Algaba, A., additional, Alonso Abreu, I., additional, Amador, M.P., additional, Amat, M., additional, Angueira, T., additional, Arajol, C., additional, Arias-González, L., additional, Arrondo Velasco, A., additional, Baldán, M., additional, Bardán García, B., additional, Bargalló García, A., additional, Barreiro de Acosta, M., additional, Barrio Andrés, J., additional, Bastida Paz, G., additional, Bastón Rey, I., additional, Batista, L., additional, Bellver Martínez, M., additional, Beltrán Niclós, B., additional, Benítez, J.M., additional, Ber Nieto, Y., additional, Bermejo, F., additional, Bernardo, D., additional, Blázquez Gómez, I., additional, Bouhmidi Assakali, A., additional, Busquets Casals, D., additional, Cabriada Nuño, J.L., additional, Calvet Calvo, X., additional, Calvo Hernández, M.V., additional, Calvo, M., additional, Camps, B., additional, Carbajo, A.Y., additional, Cardona Peitx, G., additional, Caro-Patón, T., additional, Carrillo Palau, M., additional, Carrión Bolorino, S., additional, Casanova, M.J., additional, Casellas Valdé, J.A., additional, Castaño García, A., additional, Castro Senosiain, B., additional, Ceballos, D., additional, Cerrillo, E., additional, Chacón Martínez, S., additional, Consuelo Cañete Pizarro, F., additional, de Castro Parga, M.L., additional, de Miguel, M., additional, de Francisco García, R., additional, de la Cruz Ramírez, M.D., additional, del Hoyo Francisco, J., additional, Delgado Guillena, P., additional, Desongles Corrales, T., additional, Echarri Piudo, A., additional, Espino Paisan, E., additional, Espona Quer, M., additional, Fernández Pordomingo, A., additional, Fernández Forcelledo, J.L., additional, Fernández-Tomé, S., additional, Ferreiro Iglesias, R., additional, Ferrer Bradley, I., additional, Ferrer, A., additional, Figueroa, A., additional, Gallach Montero, M., additional, García Iglesias, P., additional, García García-Lezcún, C., additional, García Ramírez, L., additional, García García, M.J., additional, García-Bosh, O., additional, Garre, A., additional, Giménez Poderós, T., additional, Gómez Irwin, L., additional, Gómez Pastrana, B., additional, Gómez Delgado, E., additional, González Lama, Y., additional, Gracia García, Á., additional, Gracia García, B., additional, Guardiola, J., additional, Guerra, I., additional, Guerra, E., additional, Guillot, V., additional, Gustmancher Saiz, S., additional, Gutiérrez Casbas, A., additional, Hernández Ramírez, V., additional, Hernando Verdugo, M.M., additional, Hernández Muniesa, B., additional, Hernanz Chaves, R., additional, Herrera Justiniano, J.M., additional, Hinojosa del Val, J, additional, Ibáñez Feijoo, S, additional, Iborra Colomino, M, additional, Iglesias Flores, E, additional, Izquierdo García, E., additional, Sampedro González, M J, additional, Lucendo, A J., additional, Jiménez García, N, additional, Leo Carnerero, E., additional, Loizaga Díaz, I., additional, López de Torre Querejazu, A, additional, López Sánchez, P, additional, Luis Parras, J, additional, Maia Boscá, M, additional, Mañosa, M, additional, Marín Pedrosa, S, additional, Marín, A, additional, Marinero, Á, additional, Marín-Jiménez, I, additional, Márquez Mosquera, L, additional, Márquez Galán, JL, additional, Martín Arranz, E, additional, Martín Arranz, MD, additional, Martínez Cadilla, J, additional, Martínez Sesmero, JM, additional, Martínez Sánchez, B, additional, Matallana, V, additional, Mateos Hernández, MI, additional, McNicholl, AG, additional, Mejuto Fernández, R, additional, Melcarne, L, additional, Menchén, L, additional, Méndez-Castrillón Rodríguez, J, additional, Merino Ochoa, O, additional, Mínguez, M, additional, Molas Ferrer, G, additional, Montoro Huguet, M, additional, Montserrat Torres, A, additional, Mora, F, additional, Moraleja Yudego, I, additional, Morales Alvarado, VJ, additional, Morales Martínez, L, additional, Morell, A, additional, Motos García, C, additional, Muñoz Alonso, F, additional, Muñoz Villafranca, MC, additional, Muñoz, JE, additional, Mur, A, additional, Nantes, Ó, additional, Navarro, P, additional, Navarro- Llavat, M, additional, Nos Mateu, P, additional, Núñez Alonso, A, additional, Núñez Ortiz, A, additional, Olivares, D, additional, Ollero Pena, V, additional, Orobitg, J, additional, Ortega, L, additional, Ortiz de Zárate, J, additional, Pallarés Manrique, H, additional, Paradela Carreiro, A, additional, Peral Ballester, L, additional, Pereira Bueno, S, additional, Pérez Martínez, I, additional, Pineda Mariño, JR, additional, Piñero Pérez, C, additional, Planas Giner, A, additional, Plaza Santos, MR, additional, Ponferrada Díaz, Á, additional, Poza Cardón, J, additional, Prieto Vicente, V, additional, Puchades, L, additional, Ramos López, L, additional, Redondo, S, additional, Riestra Menéndez, S, additional, Rivero Tirado, M, additional, Rodríguez Lago, I, additional, Rodríguez Gutiérrez, C, additional, Rodríguez, E, additional, Romero Izquierdo, S, additional, Rubio Iturria, S, additional, Ruiz Antorán, MB, additional, Ruiz, A, additional, Salazar, LF, additional, Sánchez Ulayar, A, additional, Sánchez Gómez, E, additional, Sánchez, C, additional, Sangrador, C, additional, Serra, K, additional, Spicakova, K, additional, Suárez Ferrer, C, additional, Talavera Fabuel, A, additional, Taxonera, C, additional, Tordera, M, additional, Torrella Cortés, E, additional, Tosca, J, additional, Trigo Salado, C, additional, Uriarte Estefanía, F, additional, Van Domselaar, M, additional, Vázquez Morón, JM, additional, Ventura López, P, additional, Vera, M, additional, Vicuña Arregui, M, additional, Villoria Ferrer, A, additional, Virgós Aller, T, additional, and Yáñez Feria, D, additional

Published
2019
Full Text
View/download PDF

12. ¿ES NECESARIA UNA PRIMERA COLONOSCOPIA DE SEGUIMIENTO AL AÑO EN EL GRUPO DE PACIENTES CON ADENOMAS DE ALTO RIESGO TRAS UNA COLONOSCOPIA DE CALIDAD EN EL CRIBADO POBLACIONAL DEL CÁNCER COLORRECTAL?

Author

Terán Lantarón, Á, primary, Alonso Martín, C, additional, Ruiz Bueno, P, additional, Álvarez González, S, additional, López Arias María, J, additional, Rodríguez De Lope López, C, additional, Fernández Gil, PL, additional, Castro Senosiain, B, additional, and De La Peña García, J, additional

Published
2015
Full Text
View/download PDF

15. RESECCIÓN ENDOSCÓPICA Y QUIRÚRGICA DE PÓLIPOS GRANDES

Author

Iruzubieta Coz, P, primary, Hernandez, D, additional, Terán Lantarón, Á, additional, Cabezas Delgado, J, additional, Arias Loste, MT, additional, Castro Senosiain, B, additional, Rivero, M, additional, Martin Ramos, L, additional, Menéndez, S, additional, Crespo García, J, additional, and De La Peña García, J, additional

Published
2013
Full Text
View/download PDF

20. RESULTADOS DE LA COLONOSCOPIA EN EL PROGRAMA REGIONAL DE DETECCIÓN PRECOZ DEL CÁNCER COLORRECTAL DE CANTABRIA EN EL H. U. MARQUÉS DE VALDECILLA

Author

Terán Lantarón, A, primary, De la Peña-García, J, additional, Castro Senosiain, B, additional, Fernández Gil, P, additional, Menéndez Secades, S, additional, Martín Ramos, L, additional, González de Aledo Linos, A, additional, Cabezas-González, J, additional, Díaz-Pérez, A, additional, and Bautista Henríquez, MA, additional

Published
2011
Full Text
View/download PDF

23. Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohort.

Author

Suárez Ferrer C, Mesonero Gismero F, Caballol B, Ballester MP, Bastón Rey I, Castaño García A, Miranda Bautista J, Saiz Chumillas R, Benitez JM, Sanchez-Delgado L, López-García A, Rubin de Celix C, Alonso Abreu I, Melcarne L, Plaza Santos R, Marques-Camí M, Caballero Mateos A, Gómez Díez C, Calafat M, Galan HA, Vega Vilaamil P, Castro Senosiain B, Guerro Moya A, Rodriguez Diaz CY, Spicakova K, Manceñido Marcos N, Molina G, de Castro Parga L, Rodriguez Angulo A, Cuevas Del Campo L, Rodriguez Grau MDC, Ramirez F, Gomez Pastrana B, Gonzalez Partida I, Botella Mateu B, Peña Gonzalez E, Iyo E, Elosua Gonzalez A, Sainz Arnau E, Hernandez Villalba L, Perez Galindo P, Torrealba Medina L, Monsalve Alonso S, Olmos Perez JA, Dueñas Sadornil C, Garcia Ramirez L, Martín-Arranz MD, López Sanroman A, Fernández A, Merino Murgui V, Calviño Suárez C, Flórez-Diez P, Lobato Matilla ME, Sicilia B, Soto Escribano P, Maroto Martin C, Mañosa M, and Barreiro-De Acosta M

Subjects
Humans, Aged, Male, Female, Retrospective Studies, Treatment Outcome, Antibodies, Monoclonal therapeutic use, Antibodies, Monoclonal adverse effects, Aged, 80 and over, Adalimumab therapeutic use, Adalimumab adverse effects, Ustekinumab therapeutic use, Ustekinumab adverse effects, Antibodies, Monoclonal, Humanized therapeutic use, Antibodies, Monoclonal, Humanized adverse effects, Biological Therapy adverse effects, Remission Induction, Inflammatory Bowel Diseases drug therapy
Abstract

Introduction: Biological therapies used for the treatment of inflammatory bowel disease (IBD) have shown to be effective and safe, although these results were obtained from studies involving mostly a young population, who are generally included in clinical trials. The aim of our study was to determine the efficacy and safety of the different biological treatments in the elderly population., Methods: Multicenter study was carried out in the GETECCU group. Patients diagnosed with IBD and aged over 65 years at the time of initiating biological therapy (infliximab, adalimumab, golimumab, ustekinumab or vedolizumab) were retrospectively included. Among the patients included, clinical response was assessed after drug induction (12 weeks of treatment) and at 52 weeks. Patients' colonoscopy data in week 52 were assessment, where available. Regarding complications, development of oncological events during follow-up and infectious processes occurring during biological treatment were collected (excluding bowel infection by cytomegalovirus)., Results: A total of 1090 patients were included. After induction, at approximately 12-14 weeks of treatment, 419 patients (39.6%) were in clinical remission, 502 patients (47.4%) had responded without remission and 137 patients (12.9%) had no response. At 52 weeks of treatment 442 patients (57.1%) had achieved clinical remission, 249 patients had responded without remission (32.2%) and 53 patients had no response to the treatment (6.8%). Before 52 weeks, 129 patients (14.8%) had discontinued treatment due to inefficacy, this being significantly higher (p<0.0001) for Golimumab - 9 patients (37.5%) - compared to the other biological treatments analyzed. With respect to tumor development, an oncological event was observed in 74 patients (6.9%): 30 patients (8%) on infliximab, 23 (7.14%) on adalimumab, 3 (11.1%) on golimumab, 10 (6.4%) on ustekinumab, and 8 (3.8%) on vedolizumab. The incidence was significantly lower (p=0.04) for the vedolizumab group compared to other treatments. As regards infections, these occurred in 160 patients during treatment (14.9%), with no differences between the different biologicals used (p=0.61): 61 patients (19.4%) on infliximab, 39 (12.5%) on adalimumab, 5 (17.8%) on golimumab, 22 (14.1%) on ustekinumab, and 34 (16.5%) on vedolizumab., Conclusions: Biological drug therapies have response rates in elderly patients similar to those described in the general population, Golimumab was the drug that was discontinued most frequently due to inefficacy. In our experience, tumor development was more frequent in patients who used anti-TNF therapies compared to other targets, although its incidence was generally low and that this is in line with younger patients based on previous literature., (Copyright © 2024 Elsevier España, S.L.U. All rights reserved.)

Published
2024
Full Text
View/download PDF

24. Endoscopic ultrasound-guided fine-needle aspiration cytology in the diagnosis of leiomyomas of the gastrointestinal tract.

Author

Val-Bernal JF, Martino M, Terán A, Yllera E, and Castro-Senosiain B

Subjects
Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Young Adult, Endoscopic Ultrasound-Guided Fine Needle Aspiration, Gastrointestinal Neoplasms pathology, Leiomyoma pathology
Abstract

We investigated the efficiency and accuracy of endoscopic ultrasound-guided fine-needle aspiration cytology (EUS-FNAC) in the diagnosis of gastrointestinal leiomyoma (GIL). Between January 2009 and May 2018 we performed 795 EUS-FNAC studies of lesions of the gastrointestinal (GI) tract for various clinical indications. A diagnosis of GIL by cytological and cell block study was made in 14 patients (57.1% males, mean age 53.6 years, range 22-84 years). 7 tumors (50%) were detected incidentally. The lesions ranged in size from 2 to 10cm (mean size 4.4cm). The location of the tumors was: esophagus 7 (50%), stomach 6 (42.9%) and rectum 1(7.1%). The mean size of the symptomatic tumors was 5.2cm (range 3-10cm). The follow-up of the 14 patients varied from 1 to 108 months (median 39.5 months), during which no recurrence or evidence of lesion progression was observed. Imaging alone was not sufficient for an accurate diagnosis to be made. The pathological diagnosis was based on a combination of cytological, histopathological, and immunohistochemical features. The intracytoplasmic eosinophilic globule is a useful marker of paucicellular GIL differentiating it from gastrointestinal stromal tumor and leiomyosarcoma. EUS-FNAC is a reliable, accurate, and safe method for the diagnosis of GIL., (Copyright © 2018 Sociedad Española de Anatomía Patológica. Publicado por Elsevier España, S.L.U. All rights reserved.)

Published
2019
Full Text
View/download PDF

25. Intrapancreatic accessory spleen. Report of four cases diagnosed by ultrasound-guided fine-needle aspiration biopsy.

Author

Val-Bernal JF, Martino M, Yllera-Contreras E, Castro-Senosiain B, and Bueno-Ortiz P

Subjects
Aged, Female, Humans, Male, Middle Aged, Spleen pathology, Biopsy, Fine-Needle methods, Spleen abnormalities, Ultrasonography methods
Abstract

Intrapancreatic accessory spleen (IPAS) is a congenital anomaly usually misdiagnosed as a pancreatic neoplasm. For five years and four months, we collected seven IPASs located in the tail of the pancreas in four patients diagnosed by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA). All cases had associated cell block preparations. Each patient underwent endoscopic ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI) studies. The patients ranged in age from 57 to 73 years (mean age 65.7 years old). All lesions were well-defined, 1-1.9 cm in size (mean 1.5 cm). To our knowledge, a case with four IPASs in the tail of the gland has not been previously reported. Cytological features of IPAS included a polymorphous population of hematopoietic cells admixed with occasional blood vessels. Cell blocks comprised spleen red pulp. CD8 immunostaining of cell blocks highlighted splenic endothelial cells and confirmed the diagnosis. IPAS presented as an asymptomatic lesion detected on imaging studies. It may mimic a pancreatic neoplasm, mainly a neuroendocrine tumor. The use of EUS-FNA is an essential tool in the diagnosis of the lesion. The endothelial cells of the splenic sinuses characterized by their positivity for CD8 are evident in the sections of the cell blocks. This staining is considered specific and can be used as a confirmatory marker. EUS-FNA biopsy provides a reliable diagnosis that prevents unnecessary surgery.

Published
2018

26. [Autoimmune pancreatitis. An infrequent or underdiagnosed entity? Pathological, clinical and immunological characteristics].

Author

de las Heras-Castaño G, Castro-Senosiain B, García-Suárez C, López-Hoyos M, San-Segundo D, Juanco C, and Mayorga M

Subjects
Aged, Alcoholism complications, Autoantibodies blood, Autoantibodies immunology, Autoimmune Diseases drug therapy, Autoimmune Diseases epidemiology, Autoimmune Diseases immunology, Autoimmune Diseases pathology, Carbonic Anhydrase II immunology, Cholangiopancreatography, Endoscopic Retrograde, Chronic Disease, Common Bile Duct pathology, Constriction, Pathologic, Diabetes Complications diagnosis, Humans, Immunoglobulin G blood, Immunosuppressive Agents therapeutic use, Male, Methylprednisolone therapeutic use, Pancreas pathology, Pancreatic Ducts pathology, Pancreatitis drug therapy, Pancreatitis epidemiology, Pancreatitis immunology, Pancreatitis pathology, Prevalence, Spain epidemiology, Autoimmune Diseases diagnosis, Pancreatitis diagnosis
Abstract

In the last few years, reports of pancreatic inflammatory diseases caused by immunological mechanisms and with good response to steroid treatment have increased. Although this entity has been known by a number of names, at present the most widely accepted is that of autoimmune chronic pancreatitis (ACP). The present report describes the clinical, immunological, morphological, functional and pathological characteristics of two patients recently studied at our unit and discusses currently used diagnostic tests. The two patients had a complete response to steroid therapy. In our opinion, ACP is probably underdiagnosed in Spain. The availability of morphological, pathological and serological diagnostic tools developed in recent years will help to precisely determine the epidemiology of this process. Thus, quantification of serum levels of anti-carbonic anhydrase II and IgG4 has greatly contributed to the diagnosis of ACP. These tests should be performed in patients with a possible diagnosis of ACP, those suffering from diabetes mellitus type I with impairment of exocrine function, and those with alcoholic pancreatitis and a poor response to alcohol elimination. Once we are able to diagnose and determine the real prevalence of ACP in our setting, the most appropriate therapy and prognosis of this disease can be established.

Published
2006
Full Text
View/download PDF

27. [Prognostic factors for acute pancreatitis].

Author

de Las Heras Castaño G and Castro Senosiain B

Subjects
Acute Disease, Age Factors, Biomarkers blood, Humans, Obesity complications, Prognosis, Renal Insufficiency complications, Pancreatitis blood, Pancreatitis diagnosis, Pancreatitis epidemiology, Pancreatitis etiology
Published
2001
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results